Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000227689 | SCV000291444 | likely benign | Birt-Hogg-Dube syndrome | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570789 | SCV000673429 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000601530 | SCV000727163 | likely benign | not specified | 2018-01-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV003409358 | SCV004142324 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | FLCN: BP4, BP7 |
Center for Genomic Medicine, |
RCV000601530 | SCV005090308 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005246907 | SCV005896336 | benign | Birt-Hogg-Dube syndrome 1 | 2024-10-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV003897568 | SCV004713723 | likely benign | FLCN-related disorder | 2022-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |